Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1065 | 936 | 1174 | 1244 | 1328 | 1911 |
Fund Return | 6.52% | -6.44% | 17.39% | 7.54% | 5.84% | 6.69% |
Place in category | 276 | 457 | 216 | 86 | 111 | 35 |
% in Category | 60 | 95 | 52 | 20 | 30 | 11 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Royal London FTSE 350 Tracker Fund | 5.08B | 10.08 | 8.25 | 6.32 | ||
Royal London FTSE 350 Tracker Z Fun | 5.08B | 10.06 | 8.07 | 6.28 | ||
Royal London European Growth Fund C | 2.33B | 1.65 | 3.68 | 8.14 | ||
Royal London US Tracker Z Fund Accu | 1.35B | 19.11 | 11.00 | 15.03 | ||
Royal London UK Equity Income A | 1.13B | 6.21 | 7.12 | 6.12 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GB00B2PLJH12 | 2.03B | 9.76 | 7.75 | 6.86 | ||
TB Evenlode Income B Income | 3.27B | 1.89 | 4.27 | 8.35 | ||
UK Equity Income Fund Retail Income | 135.44M | -2.33 | 7.02 | 4.93 | ||
UK Equity Income Fund Institutional | 90.25M | -2.24 | 7.61 | 5.51 | ||
UK Equity Income Fund Z Accumulatio | 662.37M | 10.40 | 7.25 | 7.07 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shell | GB00BP6MXD84 | 6.80 | 31.06 | +0.75% | |
AstraZeneca | GB0009895292 | 4.66 | 9,978.0 | -3.05% | |
Unilever | GB00B10RZP78 | 4.12 | 54.40 | +0.04% | |
Relx | GB00B2B0DG97 | 4.02 | 3,531.00 | -2.97% | |
Imperial Brands | GB0004544929 | 3.47 | 2,371.00 | +0.81% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | BUY |
Summary | Strong Sell | Strong Sell | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review